BCHE and Alzheimer disease: Currently, the cholinesterase inhibitors (ChEI) tacrine, donepezil, rivastigmine, galantamine and a partial NMDA receptor antagonist memantine are the only drugs approved by the FDA for treatment of AD [11], [12].